{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:16:20Z","timestamp":1791443780764,"version":"4.3.3"},"reference-count":74,"publisher":"Impact Journals, LLC","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,7,12]]},"DOI":"10.18632\/oncotarget.9779","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T16:38:51Z","timestamp":1464885531000},"page":"43442-43460","source":"Crossref","is-referenced-by-count":191,"title":["Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1\/2 and p38 MAPKs"],"prefix":"10.18632","volume":"7","author":[{"given":"Rafael","family":"Barreto","sequence":"first","affiliation":[{"name":"Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Waning","sequence":"additional","affiliation":[{"name":"Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA"},{"name":"Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA"},{"name":"IUPUI Center for Cachexia Research, Innovation and Therapy, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Zimmers","sequence":"additional","affiliation":[{"name":"Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA"},{"name":"Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA"},{"name":"IUPUI Center for Cachexia Research, Innovation and Therapy, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bonetto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA"},{"name":"Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA"},{"name":"IUPUI Center for Cachexia Research, Innovation and Therapy, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clnu.2012.05.009","article-title":"Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results","volume":"32","author":"Falkmer","year":"2013","journal-title":"Clin Nutr"},{"key":"2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pan.2014.11.006","article-title":"Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review","volume":"15","author":"Lyadov","year":"2015","journal-title":"Pancreatology"},{"key":"3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mco.0000165004.93707.88","article-title":"Systemic inflammation, cachexia and prognosis in patients with cancer","volume":"8","author":"Wigmore","year":"2005","journal-title":"Curr opin Clin Nutr"},{"key":"4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Ottery","year":"2011","journal-title":"Lancet oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1463-1318.2010.02206.x","article-title":"A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer: improved efficacy at the cost of increased toxicity","volume":"13","author":"Fiorentini","year":"2011","journal-title":"Colorectal Dis"},{"key":"6","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/0026-0495(95)90040-3","article-title":"Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats","volume":"44","author":"Baracos","year":"1995","journal-title":"Metabolism"},{"key":"7","first-page":"139","article-title":"Chemotherapy-induced muscle wasting: association with NF-kB and cancer cachexia","volume":"18","author":"Guttridge","year":"2008","journal-title":"Basic Appl Myol"},{"key":"8","first-page":"490804","article-title":"Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis","volume":"2012","author":"Gibson","year":"2012","journal-title":"Chemother Res Pract"},{"key":"9","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1089\/ars.2011.3965","article-title":"Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress","volume":"15","author":"St Clair","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1210\/en.2013-1179","article-title":"Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice","volume":"154","author":"Smith","year":"2013","journal-title":"Endocrinology"},{"key":"11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved","volume":"6","author":"Garcia","year":"2015","journal-title":"J cachexia, sarcopenia Muscle"},{"key":"12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle myostatin signalling is enhanced in experimental cancer cachexia","volume":"38","author":"Rossi Fanelli","year":"2008","journal-title":"Eur J clin Invest"},{"key":"13","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Lee","year":"2002","journal-title":"Science"},{"key":"14","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Gawlak","year":"2004","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jcsm.12035","article-title":"A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy","volume":"7","author":"Busquets","year":"2016","journal-title":"J cachexia, sarcopenia muscle"},{"key":"16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2174\/156800909789057015","article-title":"Deacetylase inhibitors modulate the myostatin\/follistatin axis without improving cachexia in tumor-bearing mice","volume":"9","author":"Costelli","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00726-010-0683-3","article-title":"Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by tumor necrosis factor-alpha","volume":"40","author":"Costelli","year":"2011","journal-title":"Amino Acids"},{"key":"18","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Zimmers","year":"2010","journal-title":"Biochem Biophys Res commun"},{"key":"19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Han","year":"2010","journal-title":"Cell"},{"key":"20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MCO.0b013e3283455d45","article-title":"Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity","volume":"14","author":"Baracos","year":"2011","journal-title":"Curr Opin Clin Nutr"},{"key":"21","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","article-title":"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma","volume":"21","author":"Sawyer","year":"2010","journal-title":"Ann Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00520-014-2418-6","article-title":"Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy","volume":"23","author":"Kim","year":"2015","journal-title":"Suppor Care Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/0284186X.2014.953259","article-title":"Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer","volume":"54","author":"Gronberg","year":"2015","journal-title":"Acta Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1038\/ncomms7670","article-title":"Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy","volume":"6","author":"Sandri","year":"2015","journal-title":"Nat Comm"},{"key":"25","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ajpath.2012.12.023","article-title":"Autophagic degradation contributes to muscle wasting in cancer cachexia","volume":"182","author":"Costelli","year":"2013","journal-title":"Am J Pathol"},{"key":"26","doi-asserted-by":"crossref","first-page":"e13604","DOI":"10.1371\/journal.pone.0013604","article-title":"Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition","volume":"5","author":"Costelli","year":"2010","journal-title":"PLoS one"},{"key":"27","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jcb.23151","article-title":"Cigarette smoke-induced skeletal muscle atrophy is associated with up-regulation of USP-19 via p38 and ERK MAPKs","volume":"112","author":"Guo","year":"2011","journal-title":"J Cell Biochem"},{"key":"28","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.cellsig.2006.05.004","article-title":"ERK1\/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts","volume":"18","author":"Beis","year":"2006","journal-title":"Cell Signal"},{"key":"29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.SLA.0000055225.96357.71","article-title":"Increased muscle proteasome activity correlates with disease severity in gastric cancer patients","volume":"237","author":"Baccino","year":"2003","journal-title":"Ann Surg"},{"key":"30","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1152\/japplphysiol.01419.2004","article-title":"Attenuation of skeletal muscle atrophy via protease inhibition","volume":"99","author":"Sweeney","year":"2005","journal-title":"J Appl Physiol"},{"key":"31","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1096\/fj.13-245894","article-title":"Elevated expression of activins promotes muscle wasting and cachexia","volume":"28","author":"Gregorevic","year":"2014","journal-title":"FASEB J"},{"key":"32","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-beta mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Khatiwada","year":"2015","journal-title":"Nat Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/FTD.0000000000000238","article-title":"Individual 5-Fluorouracil Dose Adjustment via Pharmacokinetic Monitoring Versus Conventional Body-Area-Surface Method: A Meta-Analysis","volume":"38","author":"Han","year":"2016","journal-title":"Ther Drug Monit"},{"key":"34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1634\/theoncologist.2011-0357","article-title":"Modeling the 5-fluorouracil area under the curve versus dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer patients receiving FOLFOX6","volume":"17","author":"McLeod","year":"2012","journal-title":"The oncologist"},{"key":"35","first-page":"403","article-title":"The combination of 5-FU, leucovorin and CPT-11 (FOLFIRI) prolongs survival through inhibition of metastasis in an orthotopic model of colon cancer","volume":"30","author":"Hoffman","year":"2010","journal-title":"Anticancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/bjc.2013.604","article-title":"The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome","volume":"109","author":"White","year":"2013","journal-title":"Br J cancer"},{"key":"37","first-page":"119","article-title":"Development of a mouse model for assessing fatigue during chemotherapy","volume":"61","author":"Toth","year":"2011","journal-title":"Comp Med"},{"key":"38","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/annonc\/mdq632","article-title":"Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study","volume":"22","author":"Koralewski","year":"2011","journal-title":"Anna Oncol"},{"key":"39","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1200\/JCO.2009.27.4860","article-title":"Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study","volume":"28","author":"Ruff","year":"2010","journal-title":"J Clin Oncol"},{"key":"40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1470-2045(15)70127-0","article-title":"Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study","volume":"16","author":"Yamazaki","year":"2015","journal-title":"Lancet Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jss.2008.05.002","article-title":"Body surface area prediction in normal, hypermuscular, and obese mice","volume":"153","author":"Zimmers","year":"2009","journal-title":"The J Surg Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13539-012-0062-x","article-title":"Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia","volume":"3","author":"Zimmers","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"43","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.biopha.2013.08.005","article-title":"Malnutrition, anorexia and cachexia in cancer patients: A mini-review on pathogenesis and treatment","volume":"67","author":"Carpi","year":"2013","journal-title":"Biomed Pharmacother"},{"key":"44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Goldberg","year":"2004","journal-title":"FASEB J"},{"key":"45","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/jcp.24611","article-title":"Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness","volume":"229","author":"Barreiro","year":"2014","journal-title":"J Cell Physiology"},{"key":"46","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1038\/emboj.2011.292","article-title":"C\/EBPbeta mediates tumour-induced ubiquitin ligase atrogin1\/MAFbx upregulation and muscle wasting","volume":"30","author":"Li","year":"2011","journal-title":"EMBO J"},{"key":"47","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1128\/MCB.24.21.9295-9304.2004","article-title":"Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy","volume":"24","author":"Glass","year":"2004","journal-title":"Mol Cell Biol"},{"key":"48","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1158\/0008-5472.CAN-05-3060","article-title":"Extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression","volume":"66","author":"Zhu","year":"2006","journal-title":"Cancer research"},{"key":"49","doi-asserted-by":"crossref","first-page":"e10230","DOI":"10.1371\/journal.pone.0010230","article-title":"Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model","volume":"5","author":"Sweeney","year":"2010","journal-title":"PloS one"},{"key":"50","doi-asserted-by":"crossref","first-page":"e2355","DOI":"10.1371\/journal.pone.0002355","article-title":"Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity","volume":"3","author":"Wood","year":"2008","journal-title":"PloS one"},{"key":"51","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.freeradbiomed.2013.08.191","article-title":"The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle","volume":"65","author":"Neufer","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"52","doi-asserted-by":"publisher","first-page":"43202","DOI":"10.18632\/oncotarget.6439","article-title":"Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations","volume":"6","author":"Penna","year":"2015","journal-title":"Oncotarget"},{"key":"53","first-page":"133","article-title":"Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting","volume":"4","author":"Polly","year":"2012","journal-title":"Aging(Albany NY)"},{"key":"54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-011-0030-x","article-title":"Intramyocellular lipid droplets increase with progression of cachexia in cancer patients","volume":"2","author":"Fearon","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"55","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/10799891003641074","article-title":"Regulation of skeletal muscle cell plasticity by the peroxisome proliferator-activated receptor gamma coactivator 1alpha","volume":"30","author":"Handschin","year":"2010","journal-title":"J Recept Signal Transduct Res"},{"key":"56","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00125-011-2068-x","article-title":"Amelioration of lipid-induced insulin resistance in rat skeletal muscle by overexpression of Pgc-1beta involves reductions in long-chain acyl-CoA levels and oxidative stress","volume":"54","author":"Turner","year":"2011","journal-title":"Diabetologia"},{"key":"57","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.bbagen.2012.11.009","article-title":"Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?","volume":"1830","author":"Lopez-Soriano","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"58","doi-asserted-by":"crossref","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Zimmers","year":"2011","journal-title":"PloS one"},{"key":"59","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrclinonc.2012.99","article-title":"Reducing the toxicity of cancer therapy: recognizing needs, taking action","volume":"9","author":"Skillings","year":"2012","journal-title":"Nat Rev Clin oncol"},{"key":"60","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.18632\/oncotarget.3483","article-title":"Skeletal muscle atrophy is attenuated in tumor-bearing mice under chemotherapy by treatment with fish oil and selenium","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget"},{"key":"61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/en.2007-0828","article-title":"Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia","volume":"149","author":"Smith","year":"2008","journal-title":"Endocrinology"},{"key":"62","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.taap.2010.11.003","article-title":"Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems","volume":"250","author":"Aleo","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"63","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2012.144","article-title":"Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma","volume":"106","author":"Sawyer","year":"2012","journal-title":"Br J Cancer"},{"key":"64","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1093\/hmg\/ddv288","article-title":"Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy","volume":"24","author":"Lee","year":"2015","journal-title":"Hum Mol Genet"},{"key":"65","first-page":"732","article-title":"Assessment of muscle mass and strength in mice","volume":"4","author":"Waning","year":"2015","journal-title":"Bonekey Rep"},{"key":"66","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1002\/art.24907","article-title":"Impaired myofibrillar function in the soleus muscle of mice with collagen-induced arthritis","volume":"60","author":"Westerblad","year":"2009","journal-title":"Arthritis Rheum"},{"key":"67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cyto.2002.1036","article-title":"Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats","volume":"19","author":"Rossi Fanelli","year":"2002","journal-title":"Cytokine"},{"key":"68","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Mitch","year":"2015","journal-title":"J Bio Chem"},{"key":"69","doi-asserted-by":"crossref","first-page":"e7767","DOI":"10.1371\/journal.pone.0007767","article-title":"BFAST: an alignment tool for large scale genome resequencing","volume":"4","author":"Nelson","year":"2009","journal-title":"PloS one"},{"key":"70","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bioinformatics\/bts731","article-title":"NGSUtils: a software suite for analyzing and manipulating next-generation sequencing datasets","volume":"29","author":"Liu","year":"2013","journal-title":"Bioinformatics"},{"key":"71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Smyth","year":"2010","journal-title":"Bioinformatics"},{"key":"72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Lash","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"73","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Eliceiri","year":"2012","journal-title":"Nat Methods"},{"key":"74","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.freeradbiomed.2006.04.030","article-title":"Oxidative stress and inflammatory response evoked by transient cerebral ischemia\/reperfusion: effects of the PPAR-alpha agonist WY14643","volume":"41","author":"Fantozzi","year":"2006","journal-title":"Free Radic Biol Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T12:07:43Z","timestamp":1596715663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":74,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2016,7,12]]}},"alternative-id":["9779","27259276"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9779","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]}}}